Insiders · Profile

FRAZIER KENNETH C

Director at Eikon Therapeutics · Executive Chair at Merck. Filing since 15 Aug 2011. CIK 0001181175

Company
Date
Role
Action
Shares
Amount
Of holding
4 Feb 2026
Director
Bought
111,111
$2.00M
opened
7 Nov 2022
Executive Chair
Sold, plan not stated
235,769
$23.47M
25.2%
4 Nov 2022
Executive Chair
Sold, plan not stated
235,000
$23.17M
25.1%
3 Nov 2022
Executive Chair
Sold, plan not stated
235,000
$23.20M
25.1%
2 Nov 2022
Executive Chair
Sold, plan not stated
300,000
$29.97M
30.0%
1 Nov 2022
Executive Chair
Sold, plan not stated
300,000
$29.94M
29.8%
31 Oct 2022
Executive Chair
Sold, plan not stated
300,000
$30.22M
29.8%
28 Oct 2022
Executive Chair
Sold, plan not stated
567,084
$56.87M
44.5%
9 Nov 2021
Executive Chair
Sold, plan not stated
663,881
$54.61M
53.1%
9 Nov 2020
Chairman, President & CEO
Sold, plan not stated
280,000
$22.80M
40.5%
20 Mar 2019
Chairman, President & CEO
Sold, plan not stated
192,736
$15.81M
19.5%
13 Mar 2019
Chairman, President & CEO
Sold, plan not stated
18,725
$1.54M
2.3%
5 Mar 2019
Chairman, President & CEO
Sold, plan not stated
6,961
$570.81K
0.9%
4 Mar 2019
Chairman, President & CEO
Sold, plan not stated
13,144
$1.08M
1.6%
22 Feb 2019
Chairman, President & CEO
Sold, plan not stated
53,961
$4.32M
7.2%
21 Feb 2019
Chairman, President & CEO
Sold, plan not stated
41,992
$3.36M
5.7%
19 Feb 2019
Chairman, President & CEO
Sold, plan not stated
42,700
$3.42M
5.8%
15 Feb 2019
Chairman, President & CEO
Sold, plan not stated
92,913
$7.44M
11.8%
5 Feb 2019
Chairman, President & CEO
Sold, plan not stated
231,566
$18.08M
25.1%
2 Oct 2018
Chairman, President & CEO
Sold, plan not stated
279,850
$20.17M
28.8%
18 Sep 2018
Chairman, President & CEO
Sold, plan not stated
279,851
$19.61M
28.8%
31 Jul 2018
Chairman, President & CEO
Sold, plan not stated
228,091
$14.83M
24.3%
10 Nov 2016
Chairman, President & CEO
Sold, plan not stated
133,920
$8.71M
20.8%
9 Nov 2016
Chairman, President & CEO
Sold, plan not stated
6,080
$395.20K
1.2%
5 Aug 2016
Chairman, President & CEO
Sold, plan not stated
392,000
$24.23M
43.5%
5 Jul 2016
Chairman, President & CEO
Sold, plan not stated
27,621
$1.60M
5.0%
1 Jul 2016
Chairman, President & CEO
Sold, plan not stated
32,379
$1.88M
5.8%
14 Apr 2016
Chairman, President & CEO
Sold, plan not stated
131,040
$7.35M
20.1%
29 Oct 2015
Chairman, President & CEO
Sold, plan not stated
18,666
$1.02M
4.1%
18 Feb 2015
Chairman, President & CEO
Sold, plan not stated
5,164
$302.96K
1.4%
9 Jan 2015
Chairman, President & CEO
Sold, plan not stated
8,840
$552.27K
2.5%
10 Dec 2014
Chairman, President & CEO
Sold, plan not stated
9,846
$590.76K
2.8%
10 Nov 2014
Chairman, President & CEO
Sold, plan not stated
10,000
$579.78K
2.8%
10 Oct 2014
Chairman, President & CEO
Sold, plan not stated
9,895
$591.03K
2.8%
10 Sep 2014
Chairman, President & CEO
Sold, plan not stated
9,814
$593.59K
2.8%
11 Aug 2014
Chairman, President & CEO
Sold, plan not stated
10,058
$573.31K
2.9%
10 Jul 2014
Chairman, President & CEO
Sold, plan not stated
9,987
$579.54K
2.8%
10 Jun 2014
Chairman, President & CEO
Sold, plan not stated
9,985
$579.75K
2.9%
9 May 2014
Chairman, President & CEO
Sold, plan not stated
10,220
$562.10K
3.0%
10 Apr 2014
Chairman, President & CEO
Sold, plan not stated
10,047
$575.11K
3.1%
11 Feb 2014
Chairman, President & CEO
Sold, plan not stated
41,520
$2.26M
13.6%
15 Aug 2011
President & CEO
Bought
32,000
$1.02M
19.9%
42 decisions on file.